Trump’s prescription drugs gambit
When the Trump administration announced its Most Favored Nation policy, it was portrayed as a simple, sensible idea. Drug companies were supposed to lower prices for Americans to match the lower prices paid by other nations. But industry analysts and economists warn that the policy is making it harder for smaller firms to compete while […]
Original Source
Read the full article at Washingtonexaminer →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.